NewsRoom Articles - Page 66 of 214

ThursdayAug 03, 2023 1:53 pm

Study Finds Link Between Food Allergies in Infants, Childhood Asthma Onset

Researchers from the Murdoch Children’s Research Institute (MCRI) in Australia have discovered a link between food allergy in infants and asthma with diminished lung function in later childhood years. The researchers believe their findings may help physicians be more vigilant regarding the respiratory health of young children dealing with food allergies. Stanford Medicine Children’s Health estimates that around 5% of children below the age of five suffer from food allergies, with the prevalence of allergies among children under the age of 18 increasing by 18% from 1997 to 2007. Furthermore, asthma affects around 6 million children below the age of…

WednesdayAug 02, 2023 1:39 pm

AI Could Make eCommerce More Virtuous, Efficient

More than two decades after companies such as Amazon took to the internet to sell products, e-commerce has taken over the world. A large portion of global trade occurs online, and companies that use the internet are among the largest on the planet. These companies have leveraged AI tools for years to boost customer experience by optimizing the search feature, personalizing customer feeds, and recommending products, among features. As the technology advanced, e-commerce companies incorporated tools such as AI-powered chatbots to improve live customer service without significantly upping costs. According to Wish’s chief product officer Mauricio Monico, artificial intelligence could…

TuesdayAug 01, 2023 10:12 am

Vitamin D Concentration Could Decide How Severe Psoriasis Gets

More than 8 million Americans are currently living with psoriasis, a topical condition that causes itchy and dry patches to develop on the skin. A recent study on the skin condition has found that the level of vitamin D may play a role in the severity of psoriasis. The study involved close to 500 cases of psoriasis from the National Health Nutrition Examination Survey (NHANES) and is among the largest studies on psoriasis. Study results revealed that an individual’s levels of vitamin D may determine how far their psoriasis advances, with increasingly severe psoriasis occurring alongside decreasing vitamin D levels…

MondayJul 31, 2023 11:39 am

Researchers Trace Glioma Brain Tumor Origins to Epigenome

Estimates from the American Cancer Society show that doctors will diagnose around 24,000 malignant spinal cord or brain tumors this year, with an estimated 18,990 people losing their lives to the condition. Gliomas are a class of tumors that grow on the brain or spinal cord, applying pressure onto crucial parts of the brain and causing symptoms such as headaches, memory loss, cognitive decline, irritability, personality changes, vision problems, seizures and speech difficulties. Gliomas can be quite hard to treat because they tend to grow quickly into the spinal cord or brain, making their removal via surgery without damaging any…

FridayJul 28, 2023 11:11 am

Review Shows AI Could Be Pivotal in Infectious Disease Prevention

The worst of the coronavirus pandemic may be in the past, but it showed just how badly a fast-spreading infectious disease could affect the world. Most countries were woefully unprepared to deal with a medical event of that magnitude, and for the most part, the world still isn’t equipped to deal with such a pandemic. Millions of lives were lost worldwide during the pandemic, and to this day thousands of people across the world are still dealing with long Covid symptoms. Researchers recently discussed the possibility of using machine learning and artificial intelligence to prevent future disease outbreaks and pandemics.…

FridayJul 28, 2023 9:45 am

Genprex Inc. (NASDAQ: GNPX) Secures Exclusivity for REQORSA(R)-Keytruda(R) Drug Combination in China with Chinese Patent

Genprex recently received a patent in China covering the use of its drug candidate REQORSA(R) immunogene therapy in combination with PD-1 antibodies, such as Keytruda(R), to treat cancers The REQORSA-Keytruda drug combination is the subject of Genprex’s ongoing Acclaim-2 clinical trial, which targets patients with advanced, metastatic non-small cell lung cancer whose disease progressed after treatment with Keytruda The company has received patent protection for the REQORSA-Keytruda drug combination in the U.S., Japan, Australia, Russia, Mexico, and China, meaning the company has secured exclusivity in many of the largest markets The granted patents, three Fast Track Designations, and positive preclinical…

ThursdayJul 27, 2023 1:07 pm

How to Leverage Relationship Marketing to Boost eCommerce, Onsite Sales

The past three decades have seen ecommerce rise from a plucky new upstart in an already established business ecosystem to one of if not the most dominant form of commerce on the globe. Companies such as Amazon revolutionized trade in a major way and allowed companies to significantly spread their reach and serve more customers than they could have previously dreamed of before. With many businesses having either merchant websites or a social media presence to help them attract and retain more customers when the pandemic hit, switching to contactless purchases and home deliveries was relatively easy. After over three…

WednesdayJul 26, 2023 12:12 pm

Data Shows Stress Could Trigger Hair Loss

Around 25% of men and 12% of women will suffer some degree of hair loss by age 30. By age 50, half of men and 25% of women can expect to experience some hair loss. Although both men and women lose between 50 to 100 hairs every day, people with hair loss don’t replace this hair as fast as they lose it. The condition affects more men than women and is often associated with increasing age, genetics, and changes in testosterone levels. Recent data now indicates that excessive hair shedding or telogen effluvium may be caused by stress as well.…

WednesdayJul 26, 2023 9:45 am

M&A Activity, Booming Sales of Anti-IL-17 Drugs Suggest Strong Upside Potential for BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV)

BiondVax, a biotechnology company focused on developing, manufacturing, and commercializing innovative immunotherapeutic products, was featured in a recent analyst report reiterating a Buy recommendation and a $70 target price The report discussed Eli Lilly’s announcement of a definitive agreement to acquire DICE Therapeutics for approximately $2.4 billion as evidence of the potential value of BiondVax in this segment of the therapeutics market DICE Therapeutics is currently evaluating its lead drug candidate, DC-806, an oral IL-17 inhibitor, in a Phase II trial, with early-stage results from the Phase I study showing a near-44% reduction in Psoriasis Area and Severity Index The…

TuesdayJul 25, 2023 11:57 am

Clinical Trial Testing Modified Viruses as Brain Cancer Treatment Begins

Researchers from Henry Ford Health’s Hermelin Brain Tumor Center have begun working on a brain cancer treatment that would use modified viruses to fight cancer cells. Hermelin Brain Tumor Center scientists are currently in the midst of a phase 1 clinical trial for a cutting-edge brain cancer treatment that uses a virus modified to destroy tumor tissue in conjunction with fractionated stereotactic radiosurgery. Brain cancers tend to be the most challenging type of cancer to treat. Their proximity to critical brain regions makes them difficult to remove via surgery because it can damage critical nerves, infect the meninges (tissue that…